Bacillus anthracis causes high-level bacteremia, strongly suggesting paralysis of the innate immune system. We have examined the effects of anthrax lethal toxin (LT) on human neutrophil chemotaxis, a process that requires actin filament assembly. Polymorphonuclear neutrophils (PMNs) treated with a sublethal concentration of LT (50 ng/mL) for 2 h demonstrated insignificant apoptosis or necrosis. However, this same concentration slowed human PMN formylmethionylleucylphenylalanine (FMLP)-stimulated chemokinesis by 160%, markedly reduced polar morphology, and rendered PMNs incapable of responding to a chemotactic gradient. These changes were accompanied by a 150% reduction in FMLP-induced actin filament assembly. One hour of exposure to LT failed to impair polarity or actin assembly, and the effects of LT were independent of mitogen-activated protein kinase kinase 1 inhibition. We conclude that 2 h of exposure to LT markedly impairs PMN actin assembly, and reductions in actin filament content are accompanied by a profound paralysis of PMN chemotaxis.
As illustrated by the index case of the 2001 bioterrorist attack in the United States, Bacillus anthracis can cause fulminant sepsis, meningitis, and death within hours [1] . The high number of bacteria in the blood stream in association with a normal initial peripheral polymorphonuclear neutrophil (PMN) count suggests that B. anthracis may impair the migration of PMNs from the bone marrow to the peripheral blood stream. Similarly, the peripheral PMN counts in the other 10 cases of inhalation anthrax associated with this attack were normal or mildly elevated at the time of hospital admission [2, 3] . In addition to defective PMN migration, the normal initial peripheral PMN counts could be the consequence of defective chemokine signaling and in-creased PMN turnover. Another characteristic feature of these cases was the development of hemorrhagic pleural effusions containing a paucity of white blood cells, a finding indicative of poor PMN delivery to a primary site of infection [4] . These clinical findings suggest an early paralysis of the innate immune system, particularly of the PMNs.
These effects on the immune system are likely to be mediated by anthrax toxin, an exotoxin that consists of 3 components: protective antigen (PA), edema factor (EF), and lethal factor (LF). PA is responsible for binding target cell receptors and ushering LF or EF into the cytoplasm [5] . LF and EF in the absence of PA are not toxic to intact cells. In recognition of this fact, the combination of PA plus LF is called "lethal toxin" (LT), and the combination of PA plus EF is called "edema toxin" (ET). EF has been previously shown to be an adenylate cyclase that increases the intracellular levels of cAMP [6] . An increase in cAMP levels inhibits human PMN phagocytosis [7] and modestly impairs chemoattractant-mediated lamellipodia extension [8] . However, animal studies suggest that, as its name implies, LF is primarily responsible for the fatal outcome of B. anthracis sepsis [9, 10] . LF is a Zn 2+ -dependant metalloprotease, which has been previously shown to cleave Figure 1 . Effects of protective antigen plus lethal factor (lethal toxin [LT] ) (50 ng/mL) on apoptosis and necrosis of polymorphonuclear neutrophils (PMNs). A, Fluorescence-activated cell sorting (FACS) analysis of anti-annexin V antibody-and propidium iodide (PI)-stained PMNs after incubation in buffer for 2 h at 37؇C. The vertical axis shows PI staining. Cells with staining intensities above the horizontal line were considered to be necrotic (0.5% of the cells). The horizontal axis represents the intensity of anti-annexin V staining. Cells to the right of the vertical line were considered to be apoptotic, and 2.5% of the cells were above this staining intensity. B, FACS analysis of identically stained PMNs incubated with LT (50 ng/mL) for 2h at 37؇C. The percentage of necrotic cells was also 0.5%, and that of apoptotic cells was 4%. C, Western blot analysis of extracts from control and LT-treated PMNs using anti-amino-terminal mitogen-activated protein kinase kinase (MEK) antibody. The arrow points to expected molecular weight of MEK. Under the conditions of our experiments, MEK was fully cleaved by LT.
mitogen-activated protein kinase kinases (MAPKKs, or MEKs) [11] . The cleavage of MEKs results in activation-induced apoptosis of macrophages [12] , and the toxic effects of LT on macrophages have been emphasized [9] . On the basis of the recent clinical data described above, we hypothesized that one mechanism by which LT could impair innate immunity is by paralyzing PMN actin-base motility. The role of PMNs in LFmediated toxicity was last addressed 2 decades ago. In those experiments, (1) PA plus LF, (2) PA plus EF, and (3) PA plus LF plus EF all increased PMN-directed migration, as measured using an agarose gel system [13] . These observations contradict our hypothesis; however, the recent clinical findings prompted us to reexamine the effects of LT on PMN chemotaxis, as well as to examine its effects on PMN actin filament assembly, the primary biochemical event responsible for the shape changes associated with ameboid movement [14] . We find that relatively low concentrations of PA plus LF (50 ng/mL) profoundly impair chemotaxis and the ability of PMNs to form polar structures. A slowing of the rate and extent of FMLP-induced PMN actin filament assembly accompanies these defects in chemotaxis. Furthermore, we have uncovered an explanation for the contradictory findings in earlier studies, and, finally, we demonstrate that the effects of LT on PMN actin assembly are independent of MEK1 inhibition.
MATERIALS AND METHODS
PMN isolation and treatment with anthrax toxins. Whole blood was collected by venous puncture from healthy volunteers and isolated using a Ficoll-Hypaque gradient medium (ICN Biomedical) as described elsewhere [15] ; this procedure yielded 99% PMNs. Informed consent was obtained from all subjects. The study followed US Department of Health and Human Services guidelines and was approved by the University of Florida Institutional Review Board. Purified cells were resuspended in 5 mL of RPMI without l-glutamine (Mediatech), and the volume was adjusted to a concentration of cells/mL. PA and 6 1.0 ϫ 10 LF were purified as described elsewhere [16] , resulting in proteins of 199% purity as assessed by Coomassie blue-stained SDS-PAGE. In most experiments, unless otherwise noted, PMNs were incubated with (1) PA plus LF (50 ng/mL) in RPMI without lglutamine (LT treated) or (2) RPMI without l-glutamine (control), for 2 h at 37ЊC in 1.5-mL tubes that were gently rotated to prevent cell clumping. Cells were studied immediately after incubation, and all experiments were completed within 3-4 h of phlebotomy. To assess LT activity, in multiple experiments, PMN extracts were subjected to Western blot analysis using an antibody directed against the amino-terminus of MEK, as described elsewhere [17] . This antibody identifies epitopes on the first 7 amino acids of MEK, the region cleaved by LF, and loss of antibody cross-reactivity indicates proteolysis by LF. Before cell lysis, PMNs were treated with a final concentration of 1 mmol/L diisoproplyfluorophosphate (Sigma), a cell-permeable, potent serine protease inhibitor that greatly reduces proteolysis in PMN extracts [18] . After cell lysis, an antiprotease cocktail (complete Mini protease inhibitor; Roche) was also added to extracts, to further block nonspecific proteolysis.
Annexin V staining, propidium iodide (PI) staining, and nitroblue tetrazolium (NBT) test. PMN annexin V staining was performed using the Annexin-V-FLUOS Staining Kit (Roche), in accordance with the manufacturer's protocol, and stained cells were subjected to flow cytometry (FACScan; BD Biosciences) using an excitation wavelength of 488 nm and emission spectrums of 518 nm to detect anti-annexin antibody and 617 nm to detect PI. For Fas-mediated apoptosis, PMNs were incubated with mouse anti-human Fas IgM (500 ng/mL) for 2 h or with nonspecific IgG (500 ng/mL), as described elsewhere [19, 20] . For LT-treated cells, anti-Fas IgM was added at the same time as LT (50 ng/mL). The NBT test was performed before and after stimulation with a final concentration of 200 ng/mL of phorbol myristate acetate (Sigma), in accordance with the manufacturer's protocol. One hundred cells were analyzed for each condition.
PMN chemokinesis, chemotaxis, and polarization. Untreated and LT-treated PMNs ( cells in 2 mL of RPMI) 5 1 ϫ 10 were added to 35-mm glass-bottom microwell dishes (MatTek Cultureware) coated with 0.1% fibronectin (Sigma). After the addition of a final concentration of 1 mmol/L FMLP, time-lapse phase-contrast images were captured at 20-s intervals using an inverted microscope (Nikon) and a cooled charge-coupled-device camera (model C5985; Hamamatsu). All images were processed using Metamorph image software (version 4.0; Universal Imaging). Velocities of PMNs were determined using the Metamorph track image program, as described elsewhere [21] . The percentage of polarized PMNs (defined as having a distinct lamellipod, or leading vale of cytoplasm, and a narrow tail, or uropod) after 4-12 min of exposure to FMLP was assessed by a blinded observer. To explore directed chemotaxis toward a gradient, a FemtoJet needle (0.5-mm tip diameter; Eppendorf) containing a needle concentration of 10 mmol/L FMLP was introduced at one corner of the coverslip and dispensed at 15 psi by use of an Eppendorf micromanipulator [22] .
PMN phalloidin staining and fluorescence-activated cell sorting (FACS) analysis. Immediately after 2 h of incubation with LT or buffer, PMNs were exposed to a final concentration of 1 mmol/L FMLP for 0, 5, 10, 15, 30, 60, or 120 s, and the reaction was stopped by the addition of a final concentration of 3.7% formalin, followed by 0.2% Triton and phalloidin Alexa 488 stain, as described elsewhere [23] . FACS analysis was performed using an excitation wavelength of 488 nm and an emission wavelength of 518 nm.
Triton X-100 insoluble cytoskeleton. For the Triton X-100 insoluble cytoskeleton experiments, higher concentrations of PMNs were required; cells/mL were purified, and the 7 1.0 ϫ 10 assay was performed exactly as described elsewhere [24] . Cells were stimulated with 1 mmol/L FMLP for 0, 20, or 40 s, and the reaction was stopped by the addition of a 1:1 volume of a 2% triton X-100 stop solution (2% triton, 160 mmol/L KCl, 40 mmol/L imidazole HCl, 20 mmol/L EGTA, and 8 mmol/L sodium azide [pH 7.0] containing complete Mini protease inhibitor [Roche]). Cells were then centrifuged, and the resulting pellet was subjected to SDS-PAGE and Coomassie blue staining. The density of the 43-kDa polypeptide (actin) was integrated using AlphaImager (version 5.5; Alpha Innotech) for each sample.
Statistical analysis. The Wilcoxon 2-tailed nonparametric test and Fischer's exact test were used to determine statistical significance. In all experiments except for FACS analysis, n refers to the number of cells analyzed. In most experiments, a minimum of 3 separate experiments were performed, unless otherwise noted.
RESULTS

PMN apoptosis and necrosis after LT treatment.
There is considerable evidence that LT can induce apoptosis in macrophages [25] . Therefore, we first utilized annexin V staining in conjunction with PI to assess PMN apoptosis and necrosis after LT treatment. As shown in figure 1, no significant increase in apoptosis or necrosis was observed in PMNs treated with 50 ng/mL LT for 2 h at 37ЊC. Both control and LT-treated cells exhibited 0.5%-5% PI staining, indicating that this concentration of LT did not induce necrosis ( figure 1 and table 1 ). These concentrations of LT also had minimal effects on apoptosis as assessed by annexin V staining (control cells vs. LT-treated cells, 2.5%-8.4% vs. 4%-8.2%, respectively) ( figure 1 and table 1) . In the experiment shown in figure 1, control PMNs exhibited 2.5% annexin V staining, whereas LT-treated cells exhibited 4% staining. In 2 subsequent experiments, control cells showed slightly higher levels of annexin V staining than did LT-treated cells. To further explore apoptosis, we also compared the effects of stimulating apoptosis in control and LT-treated PMNs by the addition of anti-Fas IgM antibody. This antibody cross-links Fas and accelerates apoptosis in PMNs [19] . As shown in table 1, we detected no significant difference in anti-Fas antibody-stimulated apoptosis between control and LT-treated PMNs. We also compared the morphology of Wright-stained control and LTtreated PMNs and found no changes characteristic of apoptosis (nuclear condensation or vacuolization of the cytoplasm) in either group during the time frame of our experiments [26] . The final concentration of toxin used in our experiments, 50 ng/mL, was sufficient to efficiently cleave MEK, as assessed by Western blot analysis ( figure 1C) . These experiments indicate that human PMNs do not undergo significant apoptosis or necrosis in response to low concentrations of active LT.
To further ensure that other PMN functions unrelated to actin-based motility were intact, we also compared the ability of control and LT-treated PMNs to reduce NBT. The reduction of this dye to a blue precipitate reflects the generation of superoxide. We found no significant differences in the percentage of NBT + cells in resting (control, 6.5%; LT-treated, 6%) or phorbol myristate acetate-stimulated (control, 92%; LT-treated, 90%) PMNs ( , Fisher's exact test). P p 1.0 PMN chemokinesis and chemotaxis. As described above, PMNs were treated with a final concentration of 50 ng/mL LT for 2 h and compared with PMNs incubated in buffer. The ability of these cells to crawl on a fibronectin-coated surface was assessed by video microscopy. First, cells were stimulated with a homogeneous solution of 1 mmol/L FMLP. As shown in figure 2A , the mean random migration velocity of LT-treated PMNs was significantly decreased, compared with that of control PMNs, and this decrease was observed during the entire 12 min of observation (figure 2B). These differences were highly significant ( ). After 5 min of stimulation with 1 mmol/ P ! .001 L FMLP, a high percentage of control PMNs formed a broad lamellipod at their front and a narrow tail or uropod at their back, which is termed a "polarized" morphology (figure 2C and 2E), although a high percentage of LT-treated PMNs remained rounded and symmetric in their morphology ( figure  2D and 2E) . Quantitation of these morphologic differences revealed a marked reduction in the percentage of polarized cells after LT treatment, and this difference was highly significant (P ! .0001) in 2 independent experiments (figure 2E). The degree of spreading on the fibronectin-coated surface was also quantified by measuring the 2-dimensional area of control and LT-treated cells. A statistically significant reduction in 2-dimensional area was observed in LT-treated cells (mean ‫ע‬ SE area, mm ) ( ), indicating a reduced ability to 2.6 n p 39 P p .013 spread (compare figure 2C with 2D) .
To explore the ability of PMNs to move toward a chemoat- tractant gradient, we used a microinjection needle, as described elsewhere [22] . Control PMNs extended large lamellipodia and crawled toward the needle ( figure 3A, left) , whereas LT-treated PMNs remained rounded and demonstrated only minimal movement. ( figure 3A, right) . Control PMNs moved at a mean ‫ע‬ SE speed of mm/s, whereas LT-treated cells 0.090 ‫ע‬ 0.003 demonstrated minimal directional movement (0.004 ‫ע‬ 0.001 mm/s) ( ) ( figure 3B ). P ! .0001 Figure 5 . Effects of treatment with the mitogen-activated protein kinase kinase inhibitor PD98059 (100 mmol/L) on FMLP-induced polymorphonuclear neutrophil (PMN) actin assembly. The graph shows the median PMN F-actin content over time after exposure to FMLP. Instead of being treated with lethal toxin, PMNs were treated with a final concentration of 100 mmol/L PD98059 for 10-15 min before exposure to FMLP. Subsequent steps were identical to those described in figure 4A . The graph is the mean of 2 experiments, both demonstrating slightly higher F-actin content in PD98059-treated PMNs than in control PMNs.
PMN actin assembly. PMN chemotaxis requires rapid assembly and disassembly of actin filaments, and the profound defects in chemotaxis that are induced by treatment with relatively low concentrations of LT encouraged us to examine chemoattractant-induced PMN actin polymerization. We used phalloidin conjugated to Alexa 488 to measure the relative increase in F-actin content on stimulation with 1 mmol/L FMLP. Phalloidin binds F-actin, and fluorescence intensity has been shown to be proportional to the F-actin content of PMNs [14] . After exposure to FMLP, the F-actin content of control PMNs rapidly increased; a significant increase was observed at the earliest time point that could be measured, 5 s (figure 4A). A peak in F-actin content was observed at 30 s. The kinetics of actin assembly was delayed in LT-treated PMNs, with no increase in actin filament content being observed at 5 s (10 separate experiments), and the peak F-actin content was significantly lower than in control PMNs. Incubation of PMNs with PA or LF alone had no effect on chemoattractant-associated actin filament assembly (data not shown). A concentration of 5 ng/mL of LT also caused significant impairment of PMN actin assembly, at both 5 and 30 s. Increasing the toxin concentration to 500 ng/mL failed to further inhibit the increase in F-actin content ( figure 4B ). However, a reduction in the time that cells were incubated with LT, from 2 to 1 h, profoundly affected LT impairment of PMN actin assembly. Under these incubation conditions, LT treatment caused minimal impairment of FMLP-induced actin assembly ( figure 4C ). This shorter incubation period also reduced toxin inhibition of chemokinesis (figure 2B, right) and abrogated toxin-induced blockade of cell polarity ( figure 2E, right) .
To confirm the results of our phalloidin staining experiments, PMN actin filament content in cells incubated with LT for 2 h was compared with that in control cells by measuring the relative actin concentrations associated with the PMN Tritoninsoluble cytoskeleton before and after exposure to FMLP. As shown in figure 4D , after FMLP exposure for 20 and 40 s, the F-actin content of LT-treated PMNs exhibited a marked reduction, compared with that of control PMNs.
One mechanism by which LT is known to impair cell function is by cleaving and inactivating MEK. To determine whether impairment of MEK mediates LT inhibition of PMN actin assembly, we examined the effects of the specific MEK1 inhibitor PD98059. Under conditions previously shown to inhibit MEK1 in PMNs [27] , we observed no inhibition of FMLP-induced PMN actin assembly. In fact, in 2 of 2 experiments, we observed a slight increase in the peak F-actin content (figure 5).
DISCUSSION
We have discovered that low concentrations of LT cause nearcomplete paralysis of directed migration by human PMNs ( figure  3 ) and also significantly impair chemokinesis and cell polarity (figure 2). Paralysis of PMNs, a vital component of the innate immune system, would help B. anthracis to establish a systemic infection before an adaptive immune response could be mounted. This profound PMN chemotactic defect is not accompanied by significant apoptosis or necrosis, indicating that the effects of anthrax toxin on cell motility are not a secondary consequence of impending cell death (figure 1). The ability of PMNs to resist apoptosis differs from that of macrophages, which, depending on the species, often undergo rapid cell death on exposure to LT. Unlike in macrophages, exposure to many inflammatory stimuli, including lipopolysaccharide, delays PMN apoptosis, and exposure to FMLP has no effect on this process [28] . In the absence of external stimuli, once they fully mature, PMNs do undergo relatively rapid programmed cell death; however, significant apoptosis does not begin for 3-4 h after cells are removed by phlebotomy [26] . Therefore, to minimize any contribution of this ongoing process, all of our experiments were performed within this time frame.
Our findings differ from those of the 1 previous study on PMN chemotaxis, performed 2 decades ago. In those experiments, PMNs were treated for 1 h (one-half the duration used in our experiments). This treatment had no significant effect on random migration (chemokinesis); however, it did result in a doubling of the speed of directed migration (chemotaxis) [13] . The shorter incubation period used in those experiments may account for these contradictory findings. The duration of LT incubation in our experiments, 2 h, was sufficient to fully cleave MEK, as assessed by Western blot analysis, which is an accepted criterion for LF activity (figure 1C) [11] . Previous studies have shown that 1.5-2 h is required for LF to fully cleave MEK [17] . Our experiments now document that incubation with LT for 1 h, compared with 2 h, markedly reduces the toxin's ability to inhibit chemoattractant-induced PMN actin assembly (figure 4C), cell polarity (figure 2E), and chemokinesis ( figure 2B) .
A major biochemical event that accompanies the shape changes required for chemotaxis and chemokinesis is the assembly of new actin filaments [29] . Normally, on being exposed to the chemoattractant FMLP, PMNs double their F-actin content within 30 s, and the increase in F-actin content is observed within 5 s of stimulation. We observed this behavior in our control PMNs. However, treatment with LT resulted in a reproducible delay in the initial increase in F-actin content, with no increase in F-actin content being observed after 5 s. Furthermore, the peak in F-actin content was consistently !50% of that observed in control PMNs ( figure 4A and 4B ). The inhibition of actin filament formation was even more profound as measured by the actin associated with the Triton insoluble cytoskeleton ( figure 4D ). This assay has been shown to detect longer actin filaments and, therefore, is a more rigorous test for new actin assembly [30] .
The mechanism by which LT impairs actin assembly is unclear. To date, 3 mechanisms have been discovered that can bring about the assembly of new actin filaments. Preformed actin filaments can be uncapped, creating free filament ends for new actin assembly; actin nucleating proteins, such as Arp2/ 3 complex, can become activated and initiate de novo actin filament assembly; and severing proteins can break apart old actin filaments, and these actin fragments can serve as the sites for new actin filament assembly [29] . The inability of higher concentrations of LF to completely block actin assembly suggests that this metalloprotease acts specifically on a limited number of these pathways (figure 4B). LF is thought to act by cleaving MEK and inhibiting its function; however, to date, MEK has not been shown to mediate actin assembly, and we show that a specific MEK1 inhibitor does not impair the extent or time course of chemoattractant-induced PMN actin assembly (figure 5). Our findings are in agreement with those of a previous study demonstrating that MEK1 inhibition does not impair PMN chemotaxis or actin filament assembly [27] . The links between the cleavage of MEK by LF and the pathogenesis of anthrax are poorly understood [31] , and recent studies suggest that some effects of LF are independent of MEK cleavage [32, 33] . Our experiments suggest that, in addition to MEK, LF could alter the function of actin or 1 or more actin regulatory proteins, and we are presently exploring these possibilities.
In conclusion, we found that LT paralyzes human PMN chemotaxis, and this paralysis is associated with a marked inhibition in chemoattractant-induced PMN actin assembly. These effects are likely to contribute to the poor initial PMN response in the peripheral blood and pleural effusions of patients with overwhelming inhalation anthrax.
